Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerance study of Posterisan corte placebo suppositories in healthy volunteers
2007-006165-32Phase 3Completed
- Sponsor
- DR. KADE Health Care
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of hydrocortisone, sponsored by DR. KADE Health Care. Primary endpoints: Incidence of intolerances and Physician-assessed tolerance. Started Mar 2008; status: completed.
02
Drugs
hydrocortisone
Beyond the preview
Go deeper on 2007-006165-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006165-32.